A dry glucose test strip using Prussian blue nanozyme and preparation method thereof
By replacing natural horseradish peroxidase with Prussian blue nanoenzyme, the problems of poor thermal stability and harsh preparation conditions of natural enzymes are solved, and the preparation of low-cost and efficient dry glucose test strips are achieved, which is suitable for emergency departments and Bedside diagnosis.
Patent Information
- Application Number
- CN202111172687.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-10-08
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2041-10-08
AI Technical Summary
The existing natural horseradish peroxidase dry glucose test strips have poor thermal stability, expensive prices and harsh preparation conditions, making it difficult to meet the simple and efficient needs of emergency departments and bedside diagnosis.
Prussian blue nanozyme is used to replace natural horseradish peroxidase, and the Prussian blue nanozyme is prepared by combining the buffer solution of adhesive, film-forming materials, glucose oxidase and peroxide substrate, adsorbing on the reaction membrane and drying Prepare dry glucose test strips.
It reduces the cost of reagent strips, improves thermal stability, simplifies production processes, is suitable for emergency departments and bedside diagnosis, and improves the competitiveness of domestic reagents.
Smart Images

Figure CN113999889B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a dry glucose test strip using Prussian blue nanozyme, belonging to the technical field of clinical diagnosis. Background Art
[0002] Most conventional clinical biochemical substances will produce hydrogen peroxide after a set series of enzyme-catalyzed reactions, which can then react with the substrate under the action of peroxidase to produce a color reaction and complete quantitative testing of the corresponding concentration index. In the emergency department or bedside diagnosis, there are high requirements for the sample volume, the simplicity of the analysis process and the reporting time of the test results. The dry chemical method of drying the substances involved in the biochemical reaction on layers of superimposed membranes can meet the needs of fingertip blood testing. It is easy to operate and can obtain results within 3 minutes. It is suitable for the emergency department and bedside diagnosis field.
[0003] Compared with the traditional wet method, the dry test strip needs to be prepared with a more concentrated enzyme solution so that it can be effectively fixed on the membrane surface to meet the corresponding working requirements. Peroxidase is the most widely used and consumed enzyme in dry chemical test strips. Industrial production of horseradish peroxidase usually uses natural horseradish as raw material, which is extracted with water and then graded with ammonium sulfate for the first time, purified with calcium phosphate gel, and then graded with ethanol, graded with ammonium sulfate for the second time, and refined by crystallization. Natural horseradish peroxidase has the following defects: (1) It is expensive. The market demand for horseradish peroxidase is huge, and it relies on imports, with a long delivery time, strict storage conditions, and high logistics costs; (2) The batch-to-batch difference in enzyme catalytic activity is large; (3) The protein structure of the enzyme has poor thermal stability. The drying process of the reagent strip may lead to a decrease in enzyme performance, which places stringent requirements on the processing technology of the reagent strip.
[0004] Therefore, it is urgent to provide a dry glucose test strip that does not use natural horseradish peroxidase. Summary of the invention
[0005] Purpose of the invention: The technical problem to be solved by the present invention is to provide a dry glucose test strip using Prussian blue nanoparticles instead of natural horseradish peroxidase, so as to solve the problems of poor thermal stability, high price and harsh preparation conditions of dry glucose test strips using horseradish peroxidase in the prior art.
[0006] The technical problem that the present invention needs to solve is to provide a method for preparing the above-mentioned dry glucose test strip using Prussian blue nanozyme.
[0007] Technical solution: To solve the above technical problems, the present invention adopts the following technical solution:
[0008] A method for preparing a dry glucose test strip using Prussian blue nanozyme comprises the following steps:
[0009] (1) adding Prussian blue nanozyme, adhesive, film-forming material, glucose oxidase, and peroxide substrate into a buffer to prepare a film-forming treatment solution (I), allowing the film-forming treatment solution (I) to be adsorbed on the reaction membrane, and drying to obtain a reaction membrane containing Prussian blue nanozyme;
[0010] Alternatively, Prussian blue nanozyme, adhesive, and film-forming material are added to a buffer solution to prepare a film-forming treatment solution (II), and the film-forming treatment solution (II) is adsorbed on the blood filter membrane; then glucose oxidase, peroxide substrate, adhesive, and film-forming material are added to a buffer solution to prepare a film-forming treatment solution (III), and the film-forming treatment solution (III) is adsorbed on the reaction membrane;
[0011] (3) stacking the diffusion membrane, the blood filter membrane, and the reaction membrane in sequence from top to bottom to obtain a dry glucose test strip using Prussian blue nanozyme;
[0012] The membrane treatment liquid can be combined with the membrane by immersion or by streaking with a streaking instrument; the membrane treated by immersion can be placed in a 45°C oven to dry for 2 hours, and the membrane treated by streaking can be placed in a 37°C oven to dry for 1 hour.
[0013] In step (1), the preparation method of the Prussian blue nanozyme is as follows:
[0014] (S1) dispersing PVP and FeCl3·6H2O in ultrapure water, heating in a water bath at 60°C with stirring, wherein the molar ratio of PVP to FeCl3·6H2O is 10:0.05-10:0.15, and the content of PVP in ultrapure water is 0.100-0.125 mmol / mL;
[0015] (S2) Disperse K4[Fe(CN)6]·3H2O in ultrapure water at 0.003-0.006 ml / mL.
[0016] (S3) using a dual-channel microfluidic injection pump, adding the K4[Fe(CN)6]·3H2O solution to the PVP and FeCl3·6H2O solutions prepared in step (S1) at a dropping rate of 20-60 mL / h. After the addition is completed, stirring is continued in a constant temperature water bath at 60° C. After the reaction is completed, the water bath is turned off and the water bath temperature is slowly lowered to room temperature.
[0017] (S4) The unreacted PVP and ions were filtered out by tangential flow filtering using a MILLPORE TTF system, and finally the aggregates were filtered out using a 0.22 μm filter membrane to obtain the Prussian blue nanozyme.
[0018] In step (1), the particle size of the Prussian blue nanozyme is 50-150 nm, preferably 110 nm; the concentration of the Prussian blue nanozyme in the buffer is 0.5-1 mg / mL, preferably 0.8 mg / mL.
[0019] In step (1), the buffer is disodium hydrogen phosphate-citric acid buffer, citric acid-sodium hydroxide-hydrochloric acid buffer or citric acid-sodium citrate buffer, and the pH of the buffer is 3.5-5.0.
[0020] In step (1), the surfactant contained in the membrane treatment liquid (I), membrane treatment liquid (II) and membrane treatment liquid (III) is Triton X-100 or CHAPS, wherein the volume fraction of Triton X-100 is 0.02%-0.1%, and the content of CHAPS is 5-10 g / L.
[0021] In step (1), the preservative contained in the membrane treatment liquid (I), membrane treatment liquid (II) and membrane treatment liquid (III) is one or a mixture of benzoic acid, sodium benzoate, sorbic acid, potassium sorbate and calcium propionate, and the content of the preservative is 0.5 to 1 g / L.
[0022] In step (1), the membrane treatment liquid (I) and the membrane treatment liquid (II) contain BSA, and the concentration of BSA is 20 to 30 g / L.
[0023] In step (1), the membrane treatment solution (I) and the membrane treatment solution (II) contain EDTA, and the concentration of EDTA is 0.5 to 1.5 g / L.
[0024] In step (1), the adhesive is hydroxypropyl cellulose or methyl vinyl ether / maleic anhydride copolymer, and the mass fraction of the adhesive is 0.5%-1%.
[0025] In step (1), the film-forming material is hydroxypropyl cellulose, methyl vinyl ether / maleic anhydride copolymer, PEG, PVP or PVA, and the mass fraction of the film-forming material is 0.5%-3%.
[0026] In step (1), the peroxide substrate is: MAOS+4-AAP, TOOS+4-AAP, CTA+4-AAP, MBTH+DMAB, MBTH+DCHBS or MBTH+ANS, and the content of the peroxide substrate in the buffer is 4-10 g / L, wherein the molar ratios of MAOS to 4-AAP, TOOS to 4-AAP, CTA to 4-AAP, MBTH to DMAB, MBTH to DCHBS, and MBTH to ANS are (1-3):1
[0027] In step (1), the concentration of glucose oxidase is 250-400 KU / L.
[0028] Preferably, the reaction membrane is a negatively charged nylon membrane or an asymmetric polyethersulfone membrane, the intermediate blood filter membrane is a glass fiber membrane or a polyethersulfone membrane, and the diffusion membrane is a polyester membrane or a nylon membrane.
[0029] The present invention uses Prussian blue nanozyme to replace the natural horseradish peroxidase commonly used in dry chemical test strips. The artificially synthesized Prussian blue nanomaterial has the characteristic of catalyzing the reaction between peroxide and substrate. Compared with natural enzymes, artificial enzymes are easy to store (can be stored in solution state at room temperature); easy to prepare, can be industrialized in large quantities, and the batch difference is easy to control compared with natural enzymes; low cost; good thermal stability, and low process requirements during the processing of reagent strips. Its widespread application in dry chemical test strips will greatly reduce the cost of reagent strips.
[0030] Beneficial effects:
[0031] The present invention discloses a dry glucose test paper using Prussian blue nanozyme and a preparation method thereof. The Prussian blue nanozyme used in the present invention is easy to synthesize, and its cost is much lower than that of natural enzymes, which reduces the cost of reagent strips, and has good thermal stability, which can effectively extend the use time of the reagent strips, relax the storage environment requirements, and also reduce the requirements for the production process of the reagent strips. At present, the dry chemical reagent strips used in clinical applications of emergency departments are mainly imported, and the application of Prussian blue in related fields will help improve the competitiveness of domestic reagents in related fields.
[0032] The successful application of artificial enzymes in diagnostic reagents has great market and clinical value. At present, the mainstream research on the application of nanoenzymes focuses on their application in solution systems. The present invention is the first to successfully prepare a dry chemical test strip that can be used to detect glucose using artificial nanoenzymes for peroxide catalysis in the diagnostic reaction process. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] Figure 1 Flow chart for the preparation of glucose test strips based on Prussian blue nanozyme (Example 1).
[0034] Figure 2 Flow chart for the preparation of glucose test strips based on Prussian blue nanozyme (Example 2).
[0035] Figure 3 Scanning electron micrograph of asymmetric polyethersulfone membrane used as reaction layer.
[0036] Figure 4 Scanning electron micrograph of asymmetric polyethersulfone membrane used as reaction layer.
[0037] Figure 5Scanning electron micrograph of Prussian blue nanoparticles.
[0038] Figure 6 Scanning electron micrograph of Prussian blue nanoparticles.
[0039] Figure 7 Distribution of Prussian blue nanoparticles on the surface of the reaction membrane (polyethersulfone membrane).
[0040] Figure 8 Distribution of Prussian blue nanoparticles on the surface of the reaction membrane (polyethersulfone membrane).
[0041] Fig. 9 Distribution of Prussian blue nanoparticles on the surface of the reaction membrane (polyethersulfone membrane).
[0042] Fig.10 Scanning electron microscopy image of the glass fiber blood filter membrane and the distribution of Prussian blue nanozyme on the glass fiber blood filter membrane.
[0043] Fig.11 Scanning electron microscopy image of the glass fiber blood filter membrane and the distribution of Prussian blue nanozyme on the glass fiber blood filter membrane.
[0044] Fig.12 Scanning electron microscopy image of the glass fiber blood filter membrane and the distribution of Prussian blue nanozyme on the glass fiber blood filter membrane.
[0045] Fig.13 Validation of the selectivity of the test strip for glucose.
[0046] Fig.14 The reagent strips were validated against clinical specimens.
[0047] Fig.15 Repeatability verification of reagent strips.
[0048] Fig.16 Accelerated stability testing of reagent strips. DETAILED DESCRIPTION
[0049] The technical solution of the present invention is further described in detail below through specific embodiments. However, it is necessary to point out that the following embodiments are only used to describe the content of the invention and do not constitute a limitation on the protection scope of the present invention.
[0050] Preparation of Prussian blue nanozyme: Weigh 1.11g (10mmol) PVP (K-30) and ultrasonically disperse it in 80mL ultrapure water. After uniform dispersion, weigh 27.03mg (0.1mmol) FeCl3·6H2O and add it to the PVP aqueous solution for ultrasonic 10min, then transfer it to a 250mL three-necked bottle in a 60℃ constant temperature water bath and stir it at a rate of 1200rpm for 30min. In addition, weigh 42.24mg (0.1mmol) K4[Fe(CN)6]·3H2O and dissolve it in 20mL ultrapure water for ultrasonic 5min to make it uniformly dispersed, then transfer it to a 20mL syringe, fix it on a WZS-50F6 double-channel microfluidic injection pump, and select a drop rate of 40mL / h. After the drop addition is completed, continue to stir at a stirring rate of 1200rpm for 1h under a 60℃ constant temperature water bath. After the reaction is completed, turn off the water bath and slowly cool it to room temperature. After the reaction was completed, the unreacted PVP and ions were filtered out using a MILLPORE TTF system tangential flow (MWCO: 50 kDa), and finally the aggregates were filtered out using a 0.22 μm filter membrane.
[0051] Embodiment 1:
[0052] Preparation method of glucose test paper using Prussian blue artificial enzyme. In this example, Prussian blue nanoparticles, glucose oxidase and substrate are on the same reaction membrane; see Figure 1
[0053] (1) Prepare a membrane treatment solution containing Prussian blue nanozyme (1 L):
[0054] Prussian blue 0.8g / L
[0055] Citric acid-sodium citrate buffer (pH = 3.5-4.5)
[0056] Citric acid 7g / L
[0057] Sodium citrate 19.6g / L
[0058] BSA 25g / L
[0059] EDTA 1g / L
[0060] Sodium benzoate 1g / L
[0061] Triton X-100 0.1% (volume fraction)
[0062] 10% Gantrez 5% (volume fraction)
[0063] Glucose oxidase 250-400KU / L
[0064] 4-Aminoantipyrine (4-AAP) 4.2g / L
[0065] N-ethyl-N(2-hydroxy-3-propanesulfonyl)-3,5-dimethylaniline (MAOS) 4.6 g / L
[0066] (2) Treat the reaction membrane with a membrane treatment solution to fix the Prussian blue nanoparticles and other necessary reactants on the membrane; this can be done by immersion or streaking. The streaking parameters are preferably 5.5 μL / cm and the streaking speed is 50 mm / s.
[0067] (3) Place the membrane treated with the above substances on a rack of appropriate size and dry it at 37°C for 1 hour.
[0068] (4) Cut the dried reaction membrane into appropriate sizes and assemble it with the blood filter membrane and the diffusion membrane into a test strip.
[0069] Embodiment 2:
[0070] Preparation method of glucose test paper using Prussian blue artificial enzyme. The materials and reagents used in this example are the same as those in Example 1, except that the Prussian blue nanoparticles in this example are adsorbed on the filter membrane alone, and the glucose oxidase and substrate are on an independent reaction membrane; see Figure 2 The filter membrane containing Prussian blue nanoparticles can be prepared and stored separately, has good stability, and can be used as a filter membrane with peroxide activity in any biochemical indicator requiring peroxide catalysis.
[0071] Embodiment 3:
[0072] Electron microscopic characterization of the Prussian blue artificial enzyme test paper reaction film in Example 1. Figures 3 to 6 For blank asymmetric polyethersulfone membrane ( Figure 3 , Figure 4 ) and scanning electron microscopy images of Prussian blue nanoparticles ( Figure 5 , Figure 6 ). From the figure, we can see that the particle size of Prussian blue nanoparticles is around 110nm, the particle size distribution is uniform, and it has a complete cubic structure and a perfect morphology, which is the basis of its nanozyme activity. The polyethersulfone membrane fiber strips are clear, and the pore size distribution is gradiently distributed from 200um on one side to 10um on the other side. This asymmetric structure facilitates the infiltration of the membrane material by liquid samples from the upper layer with large pores, and the surface of the lower layer with small pores is very dense and flat, which is conducive to the collection of light reflection signals. Figure 7-9 The following are scanning electron microscope images of Prussian blue nanoparticles distributed on the polyethersulfone membrane at different scales. It can be clearly seen that the surface of the polyethersulfone membrane is inlaid with Prussian blue nanoparticles. This shows that the Prussian blue nanoparticles have successfully maintained their complete morphology and modified the surface of the polyethersulfone membrane. This is the basis for the catalytic activity of the artificial enzyme reaction membrane.
[0073] Embodiment 4:
[0074] Electron microscopic characterization of the Prussian blue filter membrane in Example 2. Fig.10 This is an electron microscope image of an untreated filter membrane. This glass fiber structure can effectively filter out red blood cells. Fig.11 , Fig.12 It can be seen that the Prussian blue nanoparticles are completely adsorbed on the surface of the glass fiber in the filter membrane. When blood passes through the Prussian blue filter membrane, on the one hand, blood cells will be adhered to the filter membrane and will not continue to infiltrate, interfering with the reaction. On the other hand, the Prussian blue nanoparticles in the filter membrane will be eluted with the plasma and participate in the biochemical reaction in the reaction membrane. A color reaction occurs.
[0075] Embodiment 5:
[0076] The selectivity of the test strip of the present invention for glucose was compared with a sample containing 5.1 mM blood glucose using physiological saline / 5% BSA without glucose. Fig.13 It can be found that after adding 5.1mM blood glucose to the sample, the absorbance gradually decreases over time, indicating that a color reaction is occurring. In the control group, except for the color development of Prussian blue originally present in the reagent strip due to moisture when it was first added, the absorbance of the control group has basically not changed over time. This shows that the reagent strip has good selectivity for glucose.
[0077] Embodiment 6:
[0078] The test strip of the present invention tests the results of clinical specimens. The Roche blood glucose meter is used to assign values to clinical whole blood specimens. Fig.14 . Take eight specimens with uniform concentration distribution, sample 5uL, and drop it onto the test strip prepared in Example 1 for reflection absorbance analysis, record the initial absorbance of the test strip and the light reflection value 3 minutes after adding the sample, and make a ratio. Draw a correlation curve between the ratio and the corresponding specimen concentration. It can be seen that for blood sugar specimens with a glucose concentration in the range of 2-25mM, the absorbance ratio measured by the artificial enzyme glucose test strip prepared in Example 1 of the present invention has a good correlation with the glucose in the whole blood sample. It shows that the reagent strip prepared by the present invention has the potential for clinical application in glucose testing. Taking into account the relatively simple production method, low cost, temperature tolerance and other characteristics of artificial enzymes, the present invention can optimize the production process of existing clinical blood sugar test strips and reduce costs to a large extent.
[0079] Embodiment 7:
[0080] The test strip of the present invention tests the repeatability of the results. The clinical whole blood sample is assigned a value using a Roche blood glucose meter. Fig.15Two concentrations near the clinical significance and one concentration in the middle and high range were taken and measured ten times to analyze the coefficient of variation (CV). From the results, it can be seen that the reagent strip using Prussian blue nanoparticles to catalyze color change has good repeatability, CV < 5%. It meets the requirements for clinical use.
[0081] Embodiment 8:
[0082] The accelerated stability test results of the test strip of the present invention. The test strip was packaged and placed in a 45°C oven. Fresh samples were taken out regularly and tested with a Roche blood glucose meter to examine the deviation and determine the accelerated stability of the test strip at high temperature. Fig.16 From the results, it can be seen that the reagent strip using Prussian blue nanoparticles to catalyze color change can withstand an environment of 45°C for one month without significant changes in the measured value, indicating that the reagent strip of the present invention has good high temperature tolerance.
Claims
1. A method for preparing a dry glucose test strip using Prussian blue nanozyme, characterized in that: (1) Adding Prussian blue nanozyme, adhesive, glucose oxidase, and peroxide substrate into a buffer to prepare a membrane treatment solution (I), allowing the membrane treatment solution (I) to be adsorbed on a reaction membrane, drying, and obtaining a reaction membrane containing Prussian blue nanozyme, and stacking a diffusion membrane, a blood filter membrane, and a reaction membrane in sequence from top to bottom to obtain a dry glucose test strip using Prussian blue nanozyme; Or (2) adding Prussian blue nanozyme and adhesive into a buffer to prepare a membrane treatment solution (II), and allowing the membrane treatment solution (II) to be adsorbed onto the blood filter membrane; then adding glucose oxidase, peroxide substrate, and adhesive into a buffer to prepare a membrane treatment solution (III), and allowing the membrane treatment solution (III) to be adsorbed onto the reaction membrane, and stacking the diffusion membrane, the blood filter membrane, and the reaction membrane in sequence from top to bottom to obtain a dry glucose test strip using Prussian blue nanozyme; In (1) and (2), the preparation method of the Prussian blue nanozyme is as follows: (S1) dispersing PVP and FeCl3•6H2O in ultrapure water, heating in a water bath at 60°C and stirring to mix, wherein the molar ratio of PVP to FeCl3•6H2O is 10:(0.05-0.15), and the content of PVP in ultrapure water is 0.1-0.125 mmol / mL; (S2) Disperse K4 [Fe(CN)6 ]•3H2 O in ultrapure water at 0.003-0.006 mmol / mL. (S3) Using a dual-channel microfluidic syringe pump, add the K4 [Fe(CN)6 ]•3H2O solution dropwise to the PVP and FeCl3•6H2O solutions prepared in step (S1) at a dropping rate of 20-60 mL / h. After the addition is completed, continue stirring under a constant temperature water bath at 60°C. After the reaction is completed, turn off the power of the water bath and slowly reduce the temperature of the reaction solution to room temperature. (S4) Using the MILLPORE TTF system to filter out the unreacted PVP and ions by tangential flow, and finally filtering out the aggregates with a 0.22 μm filter membrane to obtain the Prussian blue nanozyme; In (1) and (2), the particle size of the Prussian blue nanozyme is 50-150 nm; the concentration of the Prussian blue nanozyme in the buffer is 0.5-1 mg / mL; In (1) and (2), the buffer is a citric acid-sodium citrate buffer, and the pH of the buffer is 3.5-5.0; In (1) and (2), the membrane treatment solution (I), membrane treatment solution (II) and membrane treatment solution (III) further contain a surfactant, wherein the surfactant is Triton X-100, wherein the volume fraction of the Triton X-100 is 0.02% to 0.1%; In (1) and (2), the membrane treatment liquid (I), membrane treatment liquid (II) and membrane treatment liquid (III) further contain a preservative, wherein the preservative is sodium benzoate and the content of the preservative is 0.5-1 g / L; The membrane treatment solution (I) and the membrane treatment solution (II) further contain BSA, and the concentration of the BSA is 20-30 g / L; The membrane treatment solution (I) and the membrane treatment solution (II) further contain EDTA, and the concentration of the EDTA is 0.5-1.5 g / L; In (1) and (2), the adhesive is methyl vinyl ether-maleic anhydride copolymer, and the volume fraction of the adhesive is 0.5% to 1%; In (1) and (2), the peroxide substrate is: MAOS+4-AAP, the content of the peroxide substrate in the buffer is 4-10 g / L, wherein the molar ratio of MAOS to 4-AAP is (1-3):1; In (1) and (2), the glucose oxidase concentration is 250-400 KU / L; In (1) and (2), the reaction membrane is a polyethersulfone membrane with an asymmetric structure, the blood filter membrane is a glass fiber membrane, and the diffusion membrane is a polyester membrane.
